Zion, IL, United States of America

James Brooks Holland


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1977-1978

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of James Brooks Holland

Introduction

James Brooks Holland is a notable inventor based in Zion, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of anesthetics. With a total of 2 patents to his name, his work has the potential to impact medical practices significantly.

Latest Patents

Holland's latest patents focus on Aminotetralins and their use in inducing anesthesia. These patents cover a compound selected from a specific formula, where R₁ is a radical chosen from higher branched or straight chain alkyl and cycloalkyl radicals containing at least six carbon atoms. R₂ is a radical selected from hydrogen, lower alkyl, and lower alkanol radicals, containing 1-3 carbon atoms, while R₃ is methoxy. The patents also encompass nontoxic pharmaceutically acceptable acid addition salts of these compounds. Furthermore, they detail the use of these compounds as local anesthetics and pharmaceutical compositions comprising these compounds as the active ingredient.

Career Highlights

James Brooks Holland is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative solutions in the pharmaceutical industry, particularly in anesthetic applications.

Collaborations

Holland has collaborated with notable coworkers such as Daniel Ambrose Dunnigan and Adolph Oscar Geiszler. These collaborations have likely contributed to the development and refinement of his patented inventions.

Conclusion

James Brooks Holland's contributions to the field of anesthetics through his patents on Aminotetralins demonstrate his innovative spirit and commitment to advancing medical science. His work continues to pave the way for new developments in pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…